Spectrochimica Acta Part A 78 (2011) 1587–1591
Contents lists available at ScienceDirect
Spectrochimica Acta Part A: Molecular and
Biomolecular Spectroscopy
journal homepage: www.elsevier.com/locate/saa
Mechanistic pathway for controlled extraction of guest molecule bound to
herring sperm DNA using -cyclodextrin
S. Syed Jaffer, Prasun Ghosh, Pradipta Purkayastha
∗
Department of Chemical Sciences, Indian Institute of Science Education and Research, Kolkata, Mohanpur 741252, WB, India
article info
Article history:
Received 4 August 2010
Received in revised form
28 December 2010
Accepted 7 February 2011
Dedicated to the 65th birth anniversary of
Professor Sanjib Bagchi.
Keywords:
Twisted intramolecular charge transfer
Guest–DNA interaction
Fluorescence
Extraction
-Cyclodextrin
abstract
trans-2-[4-(Dimethylamino)styryl]benzothiazole (DMASBT) is known to have dual emitting states where
the locally excited (LE) state is responsible for fluorescence in less polar environment and in polar milieu
fluorescence is from the twisted intramolecular charge transfer (TICT) state. This compound also under-
goes minor groove binding to herring sperm DNA (hsDNA) evidenced by the absorption spectra before
and after the binding process and an effect on DMASBT fluorescence by an anionic quencher. The binding
occurs efficiently in a 1:1 manner, i.e. one guest molecule binds to one site on the hsDNA. Instead of
following the DNA twist, the aromatic part seems to project outward. Thus, the bound molecule can be
successfully extracted out from the DNA in a controlled way by the hydrophobic cavity of -cyclodextrin
(-CD). The extraction starts even with a low concentration of -CD and increases as the concentra-
tion is increased. Absorption, steady-state and time resolved fluorescence spectroscopic methods have
been employed to explore the mechanistic pathway of binding of DMASBT to hsDNA. The mechanistic
approach toward controlled extraction of the guest molecules from hsDNA by -CD is reported and is
expected to serve a significant purpose in treatment of drug overdose.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Drug molecules that target a particular DNA sequence can selec-
tively inhibit or modulate gene expression and hence they are
valuable for a variety of chemotherapeutic strategies [1,2]. The
knowledge of the elementary steps of dynamics and the informa-
tion about static molecular structures are essentially required for
understanding the recognition process and drug action [3,4]. The
development of effective therapeutic agents that help to control
gene expression stems from the characterization of the interaction
of small molecules with DNA [5]. Small molecules serve as ana-
logues in studies of protein–nucleic acid recognition, as sensitive
probes for monitoring nucleic acid structure, provide site-specific
affinity for molecular biology and yield rationales for drug design
[6]. The total DNA content of a cell is termed the “Genome”. The
“Genome” is unique to an organism, and is the information bank
governing all life processes of the organism, DNA being the form in
which this information is stored [7]. Transcription and replication
are vital to cell survival and proliferation as well as for smooth func-
tioning of all body processes. DNA starts transcribing or replicating
on receiving a signal, which is often in the form of a regulatory
∗
Corresponding author. Tel.: +91 33 25873121; fax: +91 33 25873020.
E-mail addresses: ppurkayastha@iiserkol.ac.in, prad purk@yahoo.com
(P. Purkayastha).
protein binding to a particular region of the DNA. Thus, by mimick-
ing the binding specificity and strength of this regulatory protein
by a small molecule, the DNA function can be artificially modu-
lated, inhibited or activated. This small molecule can act as a drug
when activation or inhibition of DNA function is required to cure or
control a disease. The non-covalently bound drugs, i.e., the minor
groove binders are usually crescent shaped, which complements
the shape of the groove and facilitates binding by promoting van der
Waals interactions, whereas, intercalators introduce strong struc-
tural perturbations in DNA [8].
In the ocean of research activities on drug-DNA binding, a
few model DNAs are generally adopted to look through the out-
comes. Among them calf thymus DNA (ctDNA) and herring sperm
DNA (hsDNA) are used quite vividly [9]. Composition of isolated
deoxyribonucleoproteins shows that about 14% of the total DNA
in herring sperm nuclei is free from protamine and is bound with
non-protamine proteins in the weight ratio of nonprotamine pro-
teins to DNA of 0.25–0.30. The remaining 86% of the total DNA is
combined mainly with protamine and a small amount of nonpro-
tamine proteins; the weight ratios of protamine and nonprotamine
proteins to DNA are 0.75 and 0.08, respectively [10]. Herring sperm
DNA is used as a blocking agent in prehybridization and hybridiza-
tion procedures to minimize non-specific binding of hybridization
probe to membranes and in situ. We chose this DNA as our model
medium to study its interaction with the guest molecule followed
by extraction of the guest by a foreign agent.
1386-1425/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.saa.2011.02.005